---
title: "BrightSpring Health Services - Unit | 8-K: FY2025 Q3 Revenue: USD 3.334 B"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263160522.md"
datetime: "2025-10-28T20:21:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263160522.md)
  - [en](https://longbridge.com/en/news/263160522.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263160522.md)
generator: "portal-rs"
---

# BrightSpring Health Services - Unit | 8-K: FY2025 Q3 Revenue: USD 3.334 B

Revenue: As of FY2025 Q3, the actual value is USD 3.334 B.

EPS: As of FY2025 Q3, the actual value is USD 0.17.

EBIT: As of FY2025 Q3, the actual value is USD 87.84 M.

### Segment Revenue

-   **Total Revenue**: $3,334 million for Q3 2025, up 28.2% from $2,601 million in Q3 2024.
-   **Pharmacy Solutions Revenue**: $2,967 million for Q3 2025, up 31% from $2,266 million in Q3 2024.
-   **Provider Services Revenue**: $367 million for Q3 2025, up 9% from $336 million in Q3 2024.

### Operational Metrics

-   **Gross Profit**: $392 million for Q3 2025, up 21.3% from $323 million in Q3 2024.
-   **Net Income**: $37.5 million for Q3 2025, compared to a net loss of $25.7 million in Q3 2024.
-   **Adjusted EBITDA**: $160 million for Q3 2025, up 37.2% from $117 million in Q3 2024.

### Cash Flow

-   **Net Cash Provided by Operating Activities**: $107.9 million for Q3 2025, compared to $27.2 million in Q3 2024.

### Unique Metrics

-   **Leverage**: 3.31x as calculated under the First Lien Credit Agreement at September 30, 2025.

### Outlook / Guidance

-   BrightSpring Health Services increased its 2025 Revenue guidance to $12,500 million to $12,800 million, representing 24.1% to 27.1% growth, and reiterated Adjusted EBITDA guidance of $605 million to $615 million, representing 31.5% to 33.7% growth.

### Related Stocks

- [BTSGU.US](https://longbridge.com/en/quote/BTSGU.US.md)

## Related News & Research

- [3,759 Shares in Ferrari N.V. $RACE Acquired by X Square Capital LLC](https://longbridge.com/en/news/296700358.md)
- [Powerful Growth, Multiple Endorsements Bode Well for Oracle Stock](https://longbridge.com/en/news/296686709.md)
- [Korea Investment CORP Increases Stock Position in L3Harris Technologies Inc $LHX](https://longbridge.com/en/news/296698330.md)
- [Johnson & Johnson $JNJ Position Reduced by Oppenheimer Asset Management Inc.](https://longbridge.com/en/news/296697035.md)
- [Danske Bank A S Invests $252.05 Million in Bank of America Corporation $BAC](https://longbridge.com/en/news/296695181.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**